Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...

Several major stocks posted substantial price movements during after-hours trading sessions, reflecting investor reactions ...

It’s obvious a 95 million-year-old fossil would have a rich past — but what a CNN writer discovered about a dinosaur tooth he ...

In the summer of 2025, global trade entered one of its most turbulent periods in recent history. The second term of United States President Donald J. Trump brought with it a renewed and far more ...

OTTAWA — China is taking its dispute with Canada over steel tariffs to the World Trade Organization. Beijing filed a ...

Bitcoin Swift (BTC3), a blockchain project integrating artificial intelligence (AI) with a Proof-of-Yield (PoY) reward system ...

Strong corporate earnings, mostly stable tariff rates and the expectation of interest rate cuts have eased worries of a ...

Fresh worries about inflation soured Americans on the economy in early August, underscoring lingering anxiety about the ...

Markets are bouncing back faster than ever. For some long-term investors, that could mark a compelling case for systematic investing during downturns.

And for now, at least, Beijing views the trade-deficit-obsessed Trump as a more pragmatic and adaptable partner to work with ...

Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...